Gsk (GLAXF) Assets Average (2009 - 2026)

Gsk's Assets Average history runs 18 years deep, the most recent figure standing at $83.0 billion for Q1 2026.

• In Q1 2026, Assets Average rose 8.69% year-over-year to $83.0 billion; the TTM figure through Mar 2026 stood at $83.0 billion (up 8.69% YoY), while the FY2025 annual figure was $78.3 billion, up 4.81% from the prior year.
• Assets Average was $83.0 billion for Q1 2026 at Gsk, up from $82.0 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $91.6 billion in Q3 2022 to a low of $70.8 billion in Q4 2022.
• Historically, Assets Average has averaged $77.9 billion across 5 years, with a median of $75.9 billion in 2024.
• The sharpest annual moves came in 2022 and 2025: Assets Average tumbled 34.16% in 2022, then rose 8.81% in 2025.
• A 5-year view of Assets Average shows it stood at $70.8 billion in 2022, then grew by 6.14% to $75.2 billion in 2023, then advanced by 0.94% to $75.9 billion in 2024, then rose by 8.12% to $82.0 billion in 2025, then increased by 1.21% to $83.0 billion in 2026.
• The last three Assets Average figures came in at $83.0 billion (Q1 2026), $82.0 billion (Q4 2025), and $80.9 billion (Q3 2025), per Business Quant data.